Multiple Myeloma Comprehensive Panel Quantitative, Serum in New Delhi

The multiple myeloma comprehensive panel test includes several components: Serum Protein Electrophoresis (SPEP), Serum Immunofixation Electrophoresis (SIFE), Immunoglobulin Profile (IgG, IgA, and IgM), Free Light-chain assay, and Beta-2 Microglobulin. SPEP identifies abnormal protein levels in the blood, while SIFE further characterizes the specific type of abnormal proteins. Immunoglobulin Profile determines the levels of different immunoglobulins. The Free Light-chain assay quantifies light chains produced by myeloma cells. Beta-2 Microglobulin is a marker of disease burden. These tests aid in diagnosing multiple myeloma, assessing disease stage, and monitoring response to treatment, enabling personalized and effective management of patients with multiple myeloma.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.